Sherry (Xi) Ouyang is a seasoned professional in portfolio strategy and analytics, currently serving as Senior Director at Gilead Sciences since January 2022, after holding the position of Director. Prior experience includes over nine years at Genentech, where notable roles included Principal/Group Manager, overseeing strategic analytics across various disease franchises and market planning for oncology products. Additional experience encompasses leadership roles in market analytics at Pfizer and scientific roles at GlaxoSmithKline in drug development. Sherry holds an MBA from NYU Stern School of Business and a Master of Science in Chemistry from Stony Brook University, along with a Bachelor's degree in Applied Chemistry from Central South University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices